Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
In the Original Investigation entitled “Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial” published in the August 18, 2015, issue of JAMA,1 data were incorrect in the Tables and in the online eFigure 3. In Table 2, in the observed means row, the values shown in the Liraglutide columns (reported as −6.2, −4.8, −2.2) should have been reported as −5.9, −4.6, and −2.0, respectively; in addition, footnote “c” should have read “Number of participants not estimated.” In Table 3, in the “Increase” row in the “Change in net use of concomitant oral hypoglycemic agents” section, the first value in the Placebo column, reported as 7, should have been reported as 57. In panel “C” of eFigure 3 in the online Supplement, the value for placebo in the systolic blood pressure plot, reported as 1.2, should have been reported as 1.1. This article was corrected online.
Incorrect Data in Tables and eFigure. JAMA. 2016;315(1):90. doi:10.1001/jama.2015.17311